Acetyldinaline

DB16142InvestigationalSmall molecule

Acetyldinaline is under investigation in clinical trial NCT00005624 (CI-994 in Treating Patients With Advanced Myeloma).

Chemical structure of Acetyldinaline
Mechanism
Curator reviewed
Formula / weight
C13H13N3O · 227.267 g/mol (avg)
Also known as
Dinalin · Dinaline
Code names
NSC-328786

Resolves to

Compound
UNIIRG9G4Z82PYCAS58338-59-3ChEMBLCHEMBL1351761
Structure
InChIKeyQGMGHALXLXKCBD-UHFFFAOYSA-NSMILESNC1=CC=C(C=C1)C(=O)NC1=CC=CC=C1N

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which companies are running trials of Acetyldinaline, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In